China Energy Storage Technology Development Limited — Board/Management Information 2021

Jun 7, 2021

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

Link-Asia International MedTech Group Limited 環亞國際醫療科技集團有限公司

(incorporated in the Cayman Islands with limited liability)

(Stock code: 1143)

(1) APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR (2) CHANGES IN COMPOSITION OF BOARD COMMITTEES AND (3) COMPLIANCE WITH RULES 3.10 AND 3.21 OF THE LISTING RULES

The board (the ‘‘Board’’) of directors (the ‘‘Directors’’) of Link-Asia International MedTech Group Limited (the ‘‘Company’’) hereby announces the following changes in the Company:

APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR

Mr. Chak Chi Shing (‘‘Mr. Chak’’) has been appointed as an independent non-executive Director and the Chairman of audit committee of the Company (the ‘‘Audit Committee’’) with effect from 7 June 2021.

The biographical details of Mr. Chak are set out below:

Mr. Chak, aged 40, holds a bachelor’s degree of commerce in Accounting and Finance from Curtin University of Technology. He is a certified public accountant of Hong Kong Institute of Certified Public Accountants and Certified Public Accountant Australia. Mr. Chak has more than 15 years of experience in auditing, accounting, corporate finance and financial management and five years of experience in company secretarial matter and corporate governance in listed companies. Mr. Chak has been the independent non-executive director of SDM Group Holdings Limited (‘‘SDM’’) (stock code: 8363), a company listed on the GEM of The Stock Exchange of Hong Kong Limited (the ‘‘Stock Exchange’’) since May 2019. Mr. Chak has been appointed as the chief financial officer and company secretary of Tokyo Chuo Auction Holdings Limited (stock code: 1939), a company listed on the Main Board of the Stock Exchange since September 2019. Mr. Chak was the executive director of China Shenghai Food Holdings Company Limited (stock code: 1676), a company listed on the Main Board of the Stock Exchange, from December 2018 to September 2019, the company secretary of Bolina Holding Co., Limited (stock code: 1190), a company listed on the Main Board of the Stock Exchange until its delisting on 10 March 2021, from March 2017 to August 2018, and the chief financial officer and company secretary of SDM from March 2016 to July 2016.

– 1 –

Mr. Chak will enter into an appointment letter as an independent non-executive Director with the Company for an initial term of three years, and will be subject to retirement by rotation and re-election at general meeting of the Company in accordance with the Company’s articles of association. Mr. Chak is entitled to a directors’ fee of HK$240,000 per annum as specified in his letter of appointment, which is determined by the Board (the decision of which was based on the recommendation of the remuneration committee of the Company (the ‘‘Remuneration Committee’’)) with reference to his duties and responsibilities in the Company, the prevailing market rate and the remuneration policy of the Company. Such remuneration is subject to review by the Remuneration Committee and the Board from time to time.

Save as disclosed above, as at the date of this announcement, Mr. Chak: (i) does not hold any other positions with the Company or other members of the Group; (ii) does not have any relationships with any directors, senior management or substantial or controlling shareholders (as respectively defined in the Listing Rules) of the Company; (iii) has not at any time during the three years preceding the date of this announcement served nor is currently serving as a director of any other publicly listed companies in Hong Kong or overseas; and (iv) does not have any interests in the shares of the Company within the meaning of Part XV of the Securities and Futures Ordinance.

Saved as disclosed above, there is no other information to be disclosed pursuant to any of the requirements of Rule 13.51(2) of the Listing Rules (particularly in relation to subparagraphs (h) to (v) therein) nor are there any other matters that need to be brought to the attention of the shareholders of the Company relating to the appointment of Mr. Chak.

The Board would like to take this opportunity to welcome Mr. Chak on joining the Board.

CHANGES IN COMPOSITION OF BOARD COMMITTEES

The Board further announces that with effect from 7 June 2021, the following changes to the Audit Committee shall also take effect:

• (i) Mr. Li Huiwu will cease to be the chairman of the Audit Committee but remain as a member of the Audit Committee.

• (ii) Mr. Chak will be appointed as the Chairman of the Audit Committee.

COMPLIANCE WITH REQUIREMENTS UNDER RULES 3.10 AND 3.21 OF THE LISTING RULES

According to Rule 3.10(1) of the Listing Rules, the Company is required to have at least three independent non-executive Directors. According to Rule 3.21 of the Listing Rules, the Audit Committee must comprise a minimum of three members, and comprise non-executive Directors only.

Following the appointment of Mr. Chak,

• (i) the Company has three independent non-executive Directors, thus the number of independent non-executive Directors meets the minimum number required under Rule 3.10(1) of the Listing Rules; and

– 2 –

• (ii) the Audit Committee has three members and all members are non-executive Directors, thus meets the requirement under Rule 3.21 of the Listing Rules.

By order of the Board Link-Asia International MedTech Group Limited Lin Dailian

Chairman and executive Director

Hong Kong, 7 June 2021

As at the date of this announcement, the Board comprises Mr. Lin Dailian (Chairman), Mr. Wang Guozhen, Mr. Duan Chuanhong and Mr. Xia Xiaobing as executive Directors; Mr. Li Huiwu, Mr. Yang Weidong and Mr. Chak Chi Shing as independent non-executive Directors.

– 3 –